January 11, 2018
Rose
London-based Amiko Digital Health, which makes connected inhaler and app suite Respiro, has raised a new round of funding. The amount was not disclosed. Sanner Ventures and Breed Reply (a previous investor) led the round.
from MobiHealthNews http://ift.tt/2EyjK6A
January 11, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Survey: Hospitals' adoption of mobile strategies hits a snag- Brain-machine interface startup Paradromics closes $7M seed funding round
- Biogen launches new app, Aby, for patients with MS
- CMS relents, opens up smartphone-connected CGMs for reimbursement
- Swedish telemedicine provider Kry announces $66M Series B funding
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment